Markey McNutt

2.2k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Markey McNutt is a scholar working on Molecular Biology, Clinical Biochemistry and Surgery. According to data from OpenAlex, Markey McNutt has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Clinical Biochemistry and 5 papers in Surgery. Recurrent topics in Markey McNutt's work include Metabolism and Genetic Disorders (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). Markey McNutt is often cited by papers focused on Metabolism and Genetic Disorders (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). Markey McNutt collaborates with scholars based in United States, United Kingdom and Portugal. Markey McNutt's co-authors include Thomas A. Lagace, Jay D. Horton, Hyock Joo Kwon, J. Deisenhofer, Rita Garuti, Norma N. Anderson, Robert E. Hammer, David E. Curtis, Y K Ho and Heidi Prather and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Markey McNutt

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice

2006 548 citations Thomas A. Lagace, David E. Curtis et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markey McNutt United States	10	1.1k	509	285	217	206	20	1.6k
David E. Curtis United States	4	929 0.8×	441 0.9×	219 0.8×	156 0.7×	127 0.6×	4	1.3k
David Rhainds Canada	22	1.2k 1.0×	621 1.2×	380 1.3×	300 1.4×	114 0.6×	54	2.0k
Marianne Abifadel France	23	1.9k 1.6×	572 1.1×	507 1.8×	278 1.3×	210 1.0×	45	2.4k
Delphine Allard France	11	695 0.6×	624 1.2×	223 0.8×	153 0.7×	109 0.5×	17	1.4k
Maxime Denis Canada	22	1.4k 1.3×	931 1.8×	285 1.0×	222 1.0×	45 0.2×	27	2.0k
Chiara Ricci Italy	11	427 0.4×	187 0.4×	99 0.3×	180 0.8×	62 0.3×	18	751
Richard Lawn United States	12	606 0.5×	596 1.2×	189 0.7×	67 0.3×	30 0.1×	17	1.2k
Eric T. Alexander United States	18	692 0.6×	626 1.2×	240 0.8×	182 0.8×	15 0.1×	27	1.4k
Chao-Yuh Yang United States	15	509 0.4×	827 1.6×	235 0.8×	350 1.6×	37 0.2×	22	1.6k
Sandra Guaita‐Esteruelas Spain	16	130 0.1×	775 1.5×	345 1.2×	88 0.4×	24 0.1×	25	1.2k

Countries citing papers authored by Markey McNutt

Since Specialization

Citations

This map shows the geographic impact of Markey McNutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markey McNutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markey McNutt more than expected).

Fields of papers citing papers by Markey McNutt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markey McNutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markey McNutt. The network helps show where Markey McNutt may publish in the future.

Co-authorship network of co-authors of Markey McNutt

This figure shows the co-authorship network connecting the top 25 collaborators of Markey McNutt. A scholar is included among the top collaborators of Markey McNutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markey McNutt. Markey McNutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McNutt, Markey, Frank Rutsch, Rossana Sanchez Russo, et al.. (2025). Long‐Term Efficacy and Tolerability of Pegzilarginase in Arginase 1 Deficiency: Results of Two International Multicentre Open‐Label Extension Studies. Journal of Inherited Metabolic Disease. 48(4). e70066–e70066.

Chang, Richard, Monica Boyer, Laura Davis‐Keppen, et al.. (2024). Outcomes in 14 live births resulting from Pegvaliase-treated pregnancies in PKU-affected females. Molecular Genetics and Metabolism. 141(3). 108152–108152. 7 indexed citations

Pachnis, Panayotis, et al.. (2023). Partial N‐acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management. JIMD Reports. 64(6). 403–409. 2 indexed citations

Bjoraker, Kendra, Kristin Lindstrom, Markey McNutt, et al.. (2023). Best practice recommendations for the management of anxiety during the pegvaliase journey. Molecular Genetics and Metabolism. 141(1). 107737–107737. 3 indexed citations

McNutt, Markey, et al.. (2022). Arginase 1 Deficiency in Patients Initially Diagnosed with Hereditary Spastic Paraplegia. Movement Disorders Clinical Practice. 10(1). 109–114. 5 indexed citations

Bergstrom, Colin P., et al.. (2021). Brody Myopathy Presenting as Recurrent Rhabdomyolysis. The American Journal of Medicine. 134(7). e429–e430. 1 indexed citations

Adams, Darius J., Hans C. Andersson, Kristin Lindstrom, et al.. (2021). Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics. Molecular Genetics and Metabolism Reports. 28. 100790–100790. 14 indexed citations

Brown, E. Sherwood, et al.. (2021). A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder. European Neuropsychopharmacology. 43. 92–101. 9 indexed citations

Senkevitch, Emilee, Prech Uapinyoying, Markey McNutt, et al.. (2021). Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase. Scientific Reports. 11(1). 3580–3580. 8 indexed citations

10.

Díaz, George A., Andreas Schulze, Markey McNutt, et al.. (2020). Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency. Journal of Inherited Metabolic Disease. 44(4). 847–856. 27 indexed citations

11.

McNutt, Markey, et al.. (2019). 2264 Hyperammonemia Secondary to an Acquired Urea Cycle Disorder in a Patient With Metastatic Hepatocellular Carcinoma. The American Journal of Gastroenterology. 114(1). S1266–S1266.

12.

McNutt, Markey, Serena Banfi, Michael G. Levin, et al.. (2015). Hepatic ANGPTL3 regulates adipose tissue energy homeostasis. Proceedings of the National Academy of Sciences. 112(37). 11630–11635. 110 indexed citations

13.

McNutt, Markey, et al.. (2009). Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells. Journal of Biological Chemistry. 284(16). 10561–10570. 136 indexed citations

14.

Grefhorst, Aldo, Markey McNutt, Thomas A. Lagace, & Jay D. Horton. (2008). Plasma PCSK9 preferentially reduces liver LDL receptors in mice. Journal of Lipid Research. 49(6). 1303–1311. 159 indexed citations

15.

Kwon, Hyock Joo, Thomas A. Lagace, Markey McNutt, Jay D. Horton, & J. Deisenhofer. (2008). Molecular basis for LDL receptor recognition by PCSK9. Proceedings of the National Academy of Sciences. 105(6). 1820–1825. 330 indexed citations

16.

McNutt, Markey, Thomas A. Lagace, & Jay D. Horton. (2007). Catalytic Activity Is Not Required for Secreted PCSK9 to Reduce Low Density Lipoprotein Receptors in HepG2 Cells. Journal of Biological Chemistry. 282(29). 20799–20803. 227 indexed citations

17.

Lagace, Thomas A., David E. Curtis, Rita Garuti, et al.. (2006). Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice. Journal of Clinical Investigation. 116(11). 2995–3005. 548 indexed citations breakdown →

18.

Freebern, Wendy, Cynthia M. Haggerty, Markey McNutt, et al.. (2005). Pharmacologic profiling of transcriptional targets deciphers promoter logic. The Pharmacogenomics Journal. 5(5). 305–323. 9 indexed citations

19.

McNutt, Markey, Wenwu Cui, Irene Collins, et al.. (2005). Human promoter genomic composition demonstrates non-random groupings that reflect general cellular function. BMC Bioinformatics. 6(1). 259–259. 4 indexed citations

20.

Smith, James L., Wendy Freebern, Irene Collins, et al.. (2004). Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. Proceedings of the National Academy of Sciences. 101(32). 11554–11559. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact